Granito A, Muratori L, Pappas G, Muratori P, Ferri S, Cassani F, Lenzi M, Bianchi F B
Department of Internal Medicine, Cardioangiology, Hepatology, Alma Mater Studiorum, University of Bologna, Policlinico Sant' Orsola-Malpighi, Bologna, Italy.
Aliment Pharmacol Ther. 2005 May 15;21(10):1273-7. doi: 10.1111/j.1365-2036.2005.02488.x.
The usual onset of type 1 autoimmune hepatitis occurs at puberty or around menopause, whereas disease presentation in the advanced age is less often reported.
To assess the clinical, immunological and histological features of Type 1 autoimmune hepatitis in elderly Italian patients.
We assessed, at diagnosis, the clinical and immunological features of 76 consecutive Italian patients with type 1 autoimmune hepatitis, focusing particularly on a subgroup of 20 patients presenting at > or = 65 years (females 95%, median age 72 years, range 65-82).
In comparison with the younger group, at the time of autoimmune hepatitis diagnosis, elderly Italian patients are more often asymptomatic (25% vs. 7%; P = 0.04), are more frequently positive for antinuclear autoantibodies (95% vs. 52%; P = 0.0004) and HLA-DR4 (45% vs. 18%; P = 0.03); among the extra-hepatic manifestations, autoimmune thyroid disorders are prevalent in the elderly group (25% vs. 5%; P = 0.02). However, no difference was observed in the histological/biochemical expression of the liver disease and response to immunosuppression.
In elderly Italian patients, autoimmune hepatitis has typical serological and genetic characteristics, is more frequently asymptomatic, although prognosis and response to therapy is similar to that of younger patients. As a concomitant autoimmune thyroid disorder is common, autoimmune hepatitis should be suspected and investigated in elderly patients with autoimmune thyroid disorder and abnormal liver function tests.
1型自身免疫性肝炎通常在青春期或绝经前后发病,而老年期疾病表现的报道较少。
评估意大利老年患者1型自身免疫性肝炎的临床、免疫和组织学特征。
我们在诊断时评估了76例连续的意大利1型自身免疫性肝炎患者的临床和免疫特征,特别关注了20例年龄≥65岁的患者亚组(女性占95%,中位年龄72岁,范围65 - 82岁)。
与较年轻组相比,在自身免疫性肝炎诊断时,意大利老年患者更常无症状(25%对7%;P = 0.04),抗核自身抗体阳性率更高(95%对52%;P = 0.0004),HLA - DR4阳性率更高(45%对18%;P = 0.03);在肝外表现中,自身免疫性甲状腺疾病在老年组中更为普遍(25%对5%;P = 0.02)。然而,在肝脏疾病的组织学/生化表现及免疫抑制反应方面未观察到差异。
在意大利老年患者中,自身免疫性肝炎具有典型的血清学和遗传学特征,更常无症状,尽管预后和对治疗的反应与年轻患者相似。由于自身免疫性甲状腺疾病常与之并存,对于有自身免疫性甲状腺疾病且肝功能检查异常的老年患者,应怀疑并调查是否患有自身免疫性肝炎。